Acadia Healthcare Company, Inc. (ACHC) vs NewAmsterdam Pharma Company N.V. (NAMS)
A side-by-side comparison of Acadia Healthcare Company, Inc. and NewAmsterdam Pharma Company N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACHC
Acadia Healthcare Company, Inc.
$28.82HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
NAMS
NewAmsterdam Pharma Company N.V.
$22.07HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — ACHC vs NAMS
growth of $100 · dividends reinvested · last 6yACHC -45.5% (-9.6%/yr)NAMS +114.9% (+13.6%/yr)NAMS compounded faster over this window
ACHC NAMS
ACHC vs NAMS: by the numbers
- •ACHC is the larger company ($2.68B vs $2.58B market cap).
- •Both run net losses; ACHC's is the smaller (-33.44% vs -3644.21% net margin).
Metrics side by side
Valuation
| Metric | ACHC | NAMS |
|---|---|---|
| Forward P/E | 18.88 | N/A |
| P/S ratio | 0.80 | 362.32 |
| P/B ratio | 1.36 | 4.09 |
| EV / EBITDA | 9.49 | N/A |
Profitability
| Metric | ACHC | NAMS |
|---|---|---|
| Gross margin | 17.61% | 92.15% |
| Operating margin | 10.06% | -1002.90% |
| Net margin | -33.44% | -3644.21% |
| ROE | -56.91% | -41.10% |
| ROIC | 6.69% | -38.70% |
Growth (annualized)
| Metric | ACHC | NAMS |
|---|---|---|
| Revenue CAGR (5Y) | 8.67% | N/A |
| Total return CAGR (5Y) | -13.91% | 18.30% |
Frequently asked
- How have ACHC and NAMS total returns compared?
- Over the past 5 years, ACHC delivered -13.91% and NAMS delivered 18.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.